The number of Japanese spinouts rose 13% to 2,093 during the 2017 fiscal year, with biotech, healthcare and medical technology businesses representing 659, or 31%, of the total, Nikkei Asian Review reported on Friday. IT took the single next largest share with 614, or 29.3%, of the tally, according to a government-commissioned survey. The report…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.